University of Leicester
Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have diabetes or are at increased risk of developing diabetes. His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands, and Director of The Real World Evidence Unit. He is an NIHR Senior Investigator and Principal Investigator on several major national and international studies. He has published over 500 articles. Professor Khunti is a Fellow of the Academy of Medical Sciences and is currently an advisor to the Department of Health, Member of the International KDIGO on diabetes & CKD and Clinical Advisor for the National Institute for Health and Care Excellence (NICE) and Secretary of the Primary Care Study Group of the European Association for the Study of Diabetes. He is Past Chair of the Department of Health–RCGP Committee on Classification of Diabetes and is Past Chair of the NICE Guidelines on Prevention of Diabetes. In addition, he is Co-Director of the Diabetes MSc at Leicester University. He has won numerous awards nationally and internationally.

Moderator Of 1 Session

INDUSTRY SUPPORTED SESSION
Session Type
INDUSTRY SUPPORTED SESSION
Date
09.07.2021, Friday
Session Time
01:30 PM - 02:30 PM
Room
Industry 1
Session Description

New approaches to managing diabetes in clinical practice post-COVID - Supported by International Medical Press

Session Description:

During this symposium, expert faculty will discuss the relationship between diabetes and the development of associated complications such as cardiovascular (CV) diseases, and provide advice for managing CV risk factors. Common drivers of therapeutic inertia will also be discussed, along with practical tips on how to overcome these in the clinic. Faculty will overview the newer glucose-lowering medications before providing guidance on selecting the most appropriate agent for different individuals. All attendees will get a free handout resource summarizing key learnings from the symposium and top tips for managing people with T2D in the clinic on completion of the evaluation form.

New approaches to managing diabetes in clinical practice, symposium at Virtual Congress, United Kingdom, 09/07/2021-09/07/2021 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. .

This symposium is supported by an educational grant from Novo Nordisk A/S.

Presenter Of 2 Presentations

THERE'S MORE TO DIABETES MANAGEMENT THAN GLUCOSE

Date
09.07.2021, Friday
Session Time
01:30 PM - 02:30 PM
Room
Industry 1
Lecture Time
01:35 PM - 01:41 PM

INTRODUCTION

Date
09.07.2021, Friday
Session Time
01:30 PM - 02:30 PM
Room
Industry 1
Lecture Time
01:30 PM - 01:35 PM